Jane Street’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2K Sell
39,709
-1,822,891
-98% -$1.68M ﹤0.01% 11208
2025
Q4
$4.1M Buy
+1,862,600
New +$3M ﹤0.01% 3542
2025
Q3
Sell
-19,174
Closed -$31.1K 11945
2025
Q2
$31.1K Buy
+19,174
New +$31K ﹤0.01% 9282
2025
Q1
Sell
-22,700
Closed -$46.8K 10832
2024
Q4
$46.8K Buy
22,700
+12,648
+126% +$29.4K ﹤0.01% 8990
2024
Q3
$25.4K Buy
+10,052
New +$32.8K ﹤0.01% 9269
2024
Q2
Sell
-10,399
Closed -$77K 10333
2024
Q1
$77K Buy
+10,399
New +$87.5K ﹤0.01% 8627

Other funds holding GUTS

Jane Street's GUTS Position: Q1 2026 in Review

Jane Street reduced its Fractyl Health (GUTS) stake by 98% in Q1 2026, selling an estimated $1.68M and leaving 39,709 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #11208.

Jane Street first reported a position in GUTS in Q1 2024 and has held it in 6 quarters since. The position peaked at $4.1M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Jane Street held 39,709 shares of Fractyl Health worth $18.2K as of Q1 2026.
  • Jane Street sold 1,822,891 Fractyl Health shares in Q1 2026, an estimated $1.68M.
  • Fractyl Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11208 holding.
  • Jane Street first reported a position in Fractyl Health in Q1 2024 and has held it in 6 quarters since.
  • Jane Street's Fractyl Health position peaked at $4.1M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.